NCT02092298View on ClinicalTrials.gov

Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 8, 2014

Primary Completion Date

May 12, 2020

Study Completion Date

May 12, 2020

Conditions
Gastrointestinal Cancer
Interventions
DRUG

Mitomycin C

Mitomycin C 30 mg delivered laparoscopically for 60 minutes.

DRUG

Cisplatin

Cisplatin 200 mg delivered laparoscopically 60 minutes, 2-8 weeks after completion of systemic chemotherapy.

DRUG

Sodium Thiosulfate

Loading dose of 7.5 gm/M2 of Sodium Thiosulfate infused prior to addition of Cisplatin to the peritoneal perfusion circuit. Then a maintenance infusion of Sodium Thiosulfate 25.56 gm/M2 delivered by continuous infusion pump over 12 hours.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT02092298 - Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer | Biotech Hunter | Biotech Hunter